PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 12 filers reported holding PTC THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $627,000 | -80.4% | 544,000 | -80.9% | 0.01% | -78.3% |
| Q2 2019 | $3,191,000 | +28.3% | 2,850,000 | +14.0% | 0.02% | +64.3% |
| Q2 2018 | $2,487,000 | +209.3% | 2,500,000 | +150.0% | 0.01% | +180.0% |
| Q3 2017 | $804,000 | +1118.2% | 1,000,000 | +900.0% | 0.01% | – |
| Q1 2017 | $66,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
| PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
| Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
| Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
| LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |